Cabusas, Riza May .

HRN: 26-63-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2025
CEFUROXIME 1.5GM (VIAL)
01/31/2025
02/01/2025
IV
1.5g
Q8
S/P EXLAP; ECTOPIC PREGNANCY
Waiting Final Action 
02/01/2025
CEFUROXIME 500MG (TAB)
02/02/2025
02/09/2025
PO
500mg
BID
S/P EL, Salpingectomy Right
Waiting Final Action 
02/04/2025
CEFTRIAXONE 1G (VIAL)
02/04/2025
02/10/2025
PO
2 Grams
IV OD CA
HAP
Waiting Final Action 
02/06/2025
CEFTRIAXONE 1G (VIAL)
02/06/2025
02/12/2025
IVT
1g
OD
S/p EL
Waiting Final Action 
02/06/2025
CEFIXIME 200MG (CAP)
02/06/2025
02/12/2025
PO
1cap
Bid
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: